Long Term Safety of SL77.0499-10 (Alfuzosin) in Patients With BPH
NCT00347061
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
148
Enrollment
INDUSTRY
Sponsor class
Conditions
Benign Prostatic Hyperplasia
Interventions
DRUG:
afuzosin
Sponsor
Sanofi